133 related articles for article (PubMed ID: 37977148)
41. Discrete single-cell microRNA analysis for phenotyping the heterogeneity of acute myeloid leukemia.
Zhao X; Wang Z; Ji X; Bu S; Fang P; Wang Y; Wang M; Yang Y; Zhang W; Leung AYH; Shi P
Biomaterials; 2022 Dec; 291():121869. PubMed ID: 36327706
[TBL] [Abstract][Full Text] [Related]
42. Mutation signatures of pediatric acute myeloid leukemia and normal blood progenitors associated with differential patient outcomes.
Brandsma AM; Bertrums EJM; van Roosmalen MJ; Hofman DA; Oka R; Verheul M; Manders F; Ubels J; Belderbos ME; van Boxtel R
Blood Cancer Discov; 2021 Sep; 2(5):484-499. PubMed ID: 34642666
[TBL] [Abstract][Full Text] [Related]
43. Targeted Therapies in Pediatric Acute Myeloid Leukemia - Evolving Therapeutic Landscape.
Al-Antary ET; Gupte A; Ravindranath Y
Indian J Pediatr; 2024 Feb; 91(2):176-183. PubMed ID: 37450248
[TBL] [Abstract][Full Text] [Related]
44. Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1.
Fiskus W; Mill CP; Birdwell C; Davis JA; Das K; Boettcher S; Kadia TM; DiNardo CD; Takahashi K; Loghavi S; Soth MJ; Heffernan T; McGeehan GM; Ruan X; Su X; Vakoc CR; Daver N; Bhalla KN
Blood Cancer J; 2023 Apr; 13(1):53. PubMed ID: 37055414
[TBL] [Abstract][Full Text] [Related]
45. The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia.
Balgobind BV; Zwaan CM; Pieters R; Van den Heuvel-Eibrink MM
Leukemia; 2011 Aug; 25(8):1239-48. PubMed ID: 21566656
[TBL] [Abstract][Full Text] [Related]
46. Whole exome sequencing identifies novel mutations of epigenetic regulators in chemorefractory pediatric acute myeloid leukemia.
Zhan D; Zhang Y; Xiao P; Zheng X; Ruan M; Zhang J; Chen A; Zou Y; Chen Y; Huang G; Hu S; Wang QF; Zhu X
Leuk Res; 2018 Feb; 65():20-24. PubMed ID: 29253671
[TBL] [Abstract][Full Text] [Related]
47. Analysis of FLT3-Activating Mutations in Patients With Acute Myelogenous Leukemia in Jordan: Association With FAB Subtypes and Identification of Subgroups With Poor Prognosis.
Halahleh K; Taqash A; Abdelkhaleq H; Manasrah M; Marie L; Al-Rabi K
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):e588-e597. PubMed ID: 33811005
[TBL] [Abstract][Full Text] [Related]
48. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract][Full Text] [Related]
49. Detection of continuous hierarchical heterogeneity by single-cell surface antigen analysis in the prognosis evaluation of acute myeloid leukaemia.
Shao N; Ren C; Hu T; Wang D; Zhu X; Li M; Cheng T; Zhang Y; Zhang XE
BMC Bioinformatics; 2023 Nov; 24(1):450. PubMed ID: 38017410
[TBL] [Abstract][Full Text] [Related]
50. Preleukemic single-cell landscapes reveal mutation-specific mechanisms and gene programs predictive of AML patient outcomes.
Isobe T; Kucinski I; Barile M; Wang X; Hannah R; Bastos HP; Chabra S; Vijayabaskar MS; Sturgess KHM; Williams MJ; Giotopoulos G; Marando L; Li J; Rak J; Gozdecka M; Prins D; Shepherd MS; Watcham S; Green AR; Kent DG; Vassiliou GS; Huntly BJP; Wilson NK; Göttgens B
Cell Genom; 2023 Dec; 3(12):100426. PubMed ID: 38116120
[TBL] [Abstract][Full Text] [Related]
51. DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML).
Logan GE; Mor-Vaknin N; Braunschweig T; Jost E; Schmidt PV; Markovitz DM; Mills KI; Kappes F; Percy MJ
Blood Cells Mol Dis; 2015 Jan; 54(1):123-31. PubMed ID: 25128083
[TBL] [Abstract][Full Text] [Related]
52. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
[TBL] [Abstract][Full Text] [Related]
53. AML Subtype Is a Major Determinant of the Association between Prognostic Gene Expression Signatures and Their Clinical Significance.
Wiggers CRM; Baak ML; Sonneveld E; Nieuwenhuis EES; Bartels M; Creyghton MP
Cell Rep; 2019 Sep; 28(11):2866-2877.e5. PubMed ID: 31509748
[TBL] [Abstract][Full Text] [Related]
54. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.
Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F
Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774
[TBL] [Abstract][Full Text] [Related]
55. Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomes.
Bolouri H; Ries RE; Wiedeman AE; Hylkema T; Scheiding S; Gersuk VH; O'Brien K; Nguyen QA; Smith JL; Alice Long S; Meshinchi S
Nat Commun; 2022 Nov; 13(1):7186. PubMed ID: 36418348
[TBL] [Abstract][Full Text] [Related]
56. Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia.
Wiggers CRM; Govers AMAP; Lelieveld D; Egan DA; Zwaan CM; Sonneveld E; Coffer PJ; Bartels M
Pediatr Blood Cancer; 2019 Aug; 66(8):e27785. PubMed ID: 31044544
[TBL] [Abstract][Full Text] [Related]
57. Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia.
Xu LH; Wang Y; Chen ZY; Fang JP
J Cancer Res Clin Oncol; 2020 Apr; 146(4):1011-1020. PubMed ID: 31919567
[TBL] [Abstract][Full Text] [Related]
58. Unveiling novel insights in acute myeloid leukemia through single-cell RNA sequencing.
Zhou J; Chng WJ
Front Oncol; 2024; 14():1365330. PubMed ID: 38711849
[TBL] [Abstract][Full Text] [Related]
59. Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia.
Li K; Du Y; Cai Y; Liu W; Lv Y; Huang B; Zhang L; Wang Z; Liu P; Sun Q; Li N; Zhu M; Bosco B; Li L; Wu W; Wu L; Li J; Wang Q; Hong M; Qian S
Leukemia; 2023 Feb; 37(2):308-325. PubMed ID: 36543880
[TBL] [Abstract][Full Text] [Related]
60. Individual tumor response testing in multiple relapsed acute myeloid leukemia in children.
Styczynski J; Piatkowska M; Czyzewski K; Pogorzala M; Wysocki M
Anticancer Res; 2013 Mar; 33(3):1189-93. PubMed ID: 23482801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
